Free tool
FHLC and HRTS: how much do they overlap?
Enter any two ETFs or mutual funds to see how much of their portfolios overlap, using each fund's latest SEC holdings report.
Bottom line
Overlap between FHLC and HRTS
59% of their top holdings overlap by weight, with 15 securities in common among each fund's top 25. They share a meaningful core but differ in the rest of the portfolio. Note that FHLC holds far more positions (337 vs 45), so it is broader beyond the top names.
| Holding | % of FHLC | % of HRTS |
|---|---|---|
| Eli Lilly & Co | 13.35% | 11.52% |
| Johnson & Johnson | 8.93% | 3.59% |
| AbbVie Inc | 6.42% | 2.40% |
| UnitedHealth Group Inc | 5.44% | 5.24% |
| Merck & Co Inc | 4.66% | 4.27% |
| Thermo Fisher Scientific Inc | 3.09% | 3.97% |
| Amgen Inc | 3.00% | 1.91% |
| Abbott Laboratories | 2.66% | 2.61% |
| Gilead Sciences Inc | 2.34% | 3.43% |
| Bristol-Myers Squibb Co | 1.93% | 2.09% |
| Danaher Corp | 1.80% | 2.66% |
| Vertex Pharmaceuticals Inc | 1.76% | 2.93% |
| Medtronic PLC | 1.59% | 1.88% |
| McKesson Corp | 1.52% | 1.71% |
| Regeneron Pharmaceuticals Inc | 1.15% | 1.67% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Popular overlap checks
| Pair | Overlap | |
|---|---|---|
| VOO vs VTI | 99% | Details |
| QQQ vs VGT | 57% | Details |
| SCHD vs VYM | 24% | Details |
| VOO vs QQQ | 68% | Details |
| VTI vs VXUS | 0% | Details |
| VUG vs QQQ | 69% | Details |
| JEPI vs SCHD | 2% | Details |
Source: SEC Form N-PORT; top-25 holdings, weight-normalized